Contact
Please use this form to send email to PR contact of this press release:
Opinion/decision on a Paediatric investigation plan (PIP): (R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4-yl) pyridin-2-yl)pyrrolo[1,2- b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate (IPN60130), decision type: ,…
TO: